文献
J-GLOBAL ID:201702277379327270
整理番号:17A0529784
再発性または治療抵抗性多発性骨髄腫に対する単剤治療としての組換は循環して順列したTRAILの第II相非盲検試験【Powered by NICT】
Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma
著者 (10件):
Leng Yun
(Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University)
,
Qiu Lugui
(Department of Lymphoma Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College)
,
Hou Jian
(Department of Hematology, Shanghai Changzheng Hospital, The Second Military Medical University)
,
Zhao Yaozhong
(Department of Lymphoma Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College)
,
Zhang Xuejun
(Department of Hematology, The Second Hospital of Hebei Medical University)
,
Yang Shifang
(Beijing Sunbio Biotech Co., Ltd.)
,
Xi Hao
(Department of Hematology, Shanghai Changzheng Hospital, The Second Military Medical University)
,
Huang Zhongxia
(Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University)
,
Pan Ling
(Department of Hematology, West China Hospital, Sichuan University)
,
Chen Wenming
(Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University)
資料名:
Aizheng
(Aizheng)
巻:
35
号:
12
ページ:
699-705
発行年:
2016年
JST資料番号:
C2043A
ISSN:
1000-467X
CODEN:
AIZHE4
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
中国 (CHN)
言語:
英語 (EN)